PET/CT imaging reveals metabolic differences across HER2-low, HER2-zero and HER2-overexpressing breast cancers
A retrospective study of 248 breast cancer patients found that HER2-low, HER2-zero, and HER2-overexpressing tumors show distinct glucose metabolism patterns ...
